Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia

OBJECTIVE: To evaluate the safety and efficacy of intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation (CNV) due to pathological myopia. METHODS: Consecutive series of primary or recurrent subfoveal CNV secondary to myopia treated with intravitreal bevacizumab 1...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Yamamoto, Izumi, Rogers, Adam H, Reichel, Elias, Yates, Paul A, Duker, Jay S
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMJ Group 2007
Schlagworte:
Clinical Science - Extended Report
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC1857635/
https://ncbi.nlm.nih.gov/pubmed/16870653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjo.2006.096776
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge